|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Cerebral ischemia and neuroregeneration显示文摘Cerebral ischemia is one of the leading causes of morbidity and mortality worldwide. Although stroke(a form of cerebral ischemia)-related costs are expected to reach 240.67 billion dollars by 2030, options for treatment against cerebral ischemia/stroke are limited. All therapies except anti-thrombolytics(i.e., tissue plasminogen activator) and hypothermia have failed to reduce neuronal injury, neurological deficits, and mortality rates following cerebral ischemia, which suggests that development of novel therapies again st stroke/cerebral ischemia are urgently needed. Here, we discuss the possible mechanism(s) underlying cerebral ischemia-induced brain injury, as well as current and future novel therapies(i.e., growth factors, nicotinamide adenine dinucleotide, melatonin, resveratrol, protein kinase C isozymes, pifithrin, hypothermia, fatty acids, sympathoplegic drugs, and stem cells) as it relates to cerebral ischemia. | Reggie H.C.Lee Michelle H.H.Lee Celeste Y.C.Wu Alexandre Couto e Silva Harlee E.Possoit Tsung-Han Hsieh Alireza Minagar Hung Wen Lin | 2018 | Neural Regeneration Research2018，13，3： | 30 |
| 2 | Dabrafenib,an inhibitor of RIP3 kinase-dependent necroptosis,reduces ischemic brain injury显示文摘Ischemic brain injury triggers neuronal cell death by apoptosis via caspase activation and by necroptosis through activation of the receptor-interacting protein kinases(RIPK) associated with the tumor necrosis factor-alpha(TNF-α)/death receptor. Recent evidence shows RIPK inhibitors are neuroprotective and alleviate ischemic brain injury in a number of animal models, however, most have not yet undergone clinical trials and safety in humans remains in question. Dabrafenib, originally identified as a B-raf inhibitor that is currently used to treat melanoma, was later revealed to be a potent RIPK3 inhibitor at micromolar concentrations. Here, we investigated whether Dabrafenib would show a similar neuroprotective effect in mice subjected to ischemic brain injury by photothrombosis. Dabrafenib administered intraperitoneally at 10 mg/kg one hour after photothrombosis-induced focal ischemic injury significantly reduced infarct lesion size in C57BL6 mice the following day, accompanied by a markedly attenuated upregulation of TNF-α. However, subsequent lower doses(5 mg/kg/day) failed to sustain this neuroprotective effect after 4 days. Dabrafenib bl ocked lipopolysaccharides-induced activation of TNF-α in bone marrow-derived macrophages, suggesting that Dabrafenib may attenuate TNF-α-induced necroptotic pathway after ischemic brain injury. Since Dabrafenib is already in clinical use for the treatment of melanoma, it might be repurposed for stroke therapy. | Shelly A.Cruz Zhaohong Qin Alexandre E R.Stewart Hsiao-Huei Chen | 2018 | Neural Regeneration Research2018，13，2： | 17 |
| 3 | Opposite Interplay Between the Canonical WNT/β-Catenin Pathway and PPAR Gamma: A Potential Therapeutic Target in Gliomas显示文摘In gliomas, the canonical Wingless/Int(WNT)/b-catenin pathway is increased while peroxisome proliferator-activated receptor gamma(PPAR-c) is downregulated.The two systems act in an opposite manner. This review focuses on the interplay between WNT/b-catenin signaling and PPAR-c and their metabolic implications as potential therapeutic target in gliomas. Activation of the WNT/bcatenin pathway stimulates the transcription of genes involved in proliferation, invasion, nucleotide synthesis,tumor growth, and angiogenesis. Activation of PPAR-c agonists inhibits various signaling pathways such as the JAK/STAT, WNT/b-catenin, and PI3 K/Akt pathways,which reduces tumor growth, cell proliferation, cell invasiveness, and angiogenesis. Nonsteroidal anti-inflammatory drugs, curcumin, antipsychotic drugs, adiponectin,and sulforaphane downregulate the WNT/b-catenin pathway through the upregulation of PPAR-c and thus appear to provide an interesting therapeutic approach for gliomas.Temozolomide(TMZ) is an antiangiogenic agent. The downstream action of this opposite interplay may explain the TMZ-resistance often reported in gliomas. | AlexANDre Vallée Yves Lecarpentier Rémy Guillevin Jean-Noёl Vallée | 2018 | Neuroscience Bulletin2018，34，3： | 7 |
| 4 | Resistance and susceptibility of alfalfa (Medicago sativa L.) cultivars to the aphid Therioaphis maculata (Homoptera: Aphididae): insect biology and cultivar evaluation显示文摘蚜虫 Therioaphis maculata 的抽象生物学在苜蓿(Medicago sativa L.) 上被学习,包括四抵抗(Mesa-Sirsa, CUF101,贝克和 Lahontan ) 并且二易受影响(弧和 Caliverde ) 苜蓿栽培变种,并且大多数之一收割了巴西栽培变种, Crioula。在控制条件下面,抗生现象(即,减少的长寿,肥沃和蚜虫的增加的死亡) 主要在抵抗苜蓿栽培变种上被观察,除了在 Lahontan 上。Crioula 似乎对蚜虫容忍。现在的数据支持栽培变种的地理限制用法,并且我们作为抗生现象的来源建议贝克和 Mesa-Sirsa,并且提供热带 T 的生物信息。苜蓿上的 maculata 遗传因子型。 | ALEXANDRE DE ALMEIDA E SILVA ELENICE MOURO VARANDA JOSE RICARDO BAROSELA | 2006 | Insect Science2006，13，1： | 5 |
| 5 | Autoimmune hepatitis in childhood: The role of genetic and immune factors显示文摘Autoimmune hepatitis (AIH) is a rare chronic inflammatory disease of the liver, which affects a group of patients who lost their immunological tolerance to antigens of the liver. It is clinically characterized by hypergammaglobulinemia, elevated liver enzymes, presence of autoantibodies and histological changes. Although being rare in children, it represents a serious cause of chronic hepatic disease that can lead to cirrhosis and hepatic failure. Clinical findings, exclusion of more common liver disorders and the detection of antibodies antinuclear antibodies, smooth muscle antibodies and anti-LKM1 are usually enough for diagnosis on clinical practice. The pathogenic mechanisms that lead to AIH remain obscure, but some research findings suggest the participation of immunologic and genetic factors. It is not yet knew the triggering factor or factors that stimulate inflammatory response. Several mechanisms proposed partially explain the immunologic findings of AIH. The knowledge of immune factors evolved might result in better markers of prognosis and response to treatment. In this review, we aim to evaluate the findings of research about genetic and immune markers and their perspectives of application in clinical practice especially in pediatric population. | Priscila Menezes Ferri Liu Débora Marques de Miranda Eleonora Druve Tavares Fagundes Alexandre Rodrigues Ferreira Ana Cristina Simoes e Silva | 2013 | World Journal of Gastroenterology2013，19，28： | 3 |
| 6 | Diagnostic criteria for autoimmune hepatitis in children: A challenge for pediatric hepatologists显示文摘Autoimmune hepatitis (AIH) is a progressive inflammatory liver disorder that is rare in children and adolescents. AIH has a broad clinical spectrum and a quick response to treatment with corticosteroids and immunosuppressive medication. The available diagnosis criteria have limitations and should be evaluated in pediatric populations. Recently, some studies reported that the 2008 simplified diagnostic criteria for AIH could be used in children with high sensibility and specificity. In addition, the authors reported that globulin and immunoglobulin G levels can be used interchangeably for diagnostic purposes. They also demonstrated that the 2008 simplified criteria fail in identifying patients with fulminant hepatic failure. Here, we discuss the limitations of the use of these criteria in pediatric patients and the requirement of more studies to improve the diagnosis of AIH in children. | Priscila Menezes Ferri Alexandre Rodrigues Ferreira Débora Marques Miranda Ana Cristina Sim■es e Silva | 2012 | World Journal of Gastroenterology2012，18，33： | 3 |
| 7 | Compliant joint design principles for high compressive load situations 显示文摘 | Alexandre E G Spencer P M Lan-y L H | 2005 | Journal of Mechanical Design2005，127，4： | 1 |
| 8 | Immunochromatographic methods in food analysis显示文摘 | Boris B D Nadezhda A B Alexandr E U | 2013 | Trends in Analytical Chemistry2013，55，： | 1 |
| 9 | Spatial variation of soil respiration across a topographic gradient in a tropical rain forest in French Guiana显示文摘 | Daniel E Alexandre B Damien B | 2006 | Journal of Tropical Ecology2006，22，： | 1 |
| 10 | Subglottic secretion drainage for preventing ventilator associated pneumonia:a meta-analysis显示文摘 | Frost SA Azeem A Alexandrou E | 2013 | Aust Crit Care2013，26，4： | 1 |
| 11 | Cryopreserved human hepatocytes in suspension are a convenient high throughput tool for the prediction of metabolic clearance显示文摘 | JOUIN D BLANCHARD N ALEXANDRE E | 2006 | Eur J Pharm Biopharm2006，63，3： | 1 |
| 12 | Systematic review: potential preventive effects of statins against oesophageal adenocarcinoma显示文摘 | Alexandre L Clark AB Cheong E | 2012 | Aliment Pharmacol Ther2012，36，4： | 1 |
| 13 | Obesity,hypertension,and chronic kidney disease显示文摘 | Michael E Hall Jussara M do Carmo Alexandre A da Silva et | 2014 | Int JNephrol Renovasc Dis2014，7，： | 1 |
| 14 | Clinicopathological and prognostic significance of vascular endothelial growth factors(VEGF) -C and-D and VEGF receptor 3 in invasive breast carcinoma显示文摘 | Mylona E Alexandrou P MpakMi A | 2007 | Eur J Surg Oncol2007，33，3： | 1 |
| 15 | Clinicopathologieal and prognostic significance of vascular endothelial growth factors (VEGF)-C and-D and VEGF receptor 3 in invasive breast carcinoma 显示文摘 | Mylona E Alexandrou P Mpakali A | 2007 | Eur J Surg Oncol2007，33，3： | 1 |
| 16 | Safety and phannacokinetics of escalated doses of weekly intra- venous infusion of CCI-779, a novel mTOR inhibitor, in patients with cancer 显示文摘 | Raymond E Alexandre J Faivre S | 2004 | J Clin Oncol2004，22，12： | 1 |
| 17 | Spawning of turbot(Scophthalmus maximus) in captivity显示文摘 | Devauchelle N Alexandre J C Corre L E N | 1988 | Aquaculture1988，69，： | 1 |
| 18 | Systematic review: potential preventive effects of statins against oesophageal adenocarcinoma 显示文摘 | Alexandre L Clark AB Cheong E | 2012 | Aliment Pharmacol Ther2012，36，4： | 1 |
| 19 | Laparseopie treatment of a hemocholecyst 显示文摘 | Barhon Remis E Mar! nez Men6ndez A Alexandre Hurle E | 2014 | Cir Esp2014，92，4： | 1 |
| 20 | Expression of Ki-67 and squamous intraepithelial lesions are related with HPV in endocervical adenocareinoma显示文摘 | Cambruzzi E Zettler CG Alexandre | 2005 | Pathol Oncol Res2005，11，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员